Author: Li, Shi-fang; Zhao, Fu-rong; Shao, Jun-jun; Xie, Yin-li; Chang, Hui-yun; Zhang, Yong-guang
Title: Interferon-omega: Current status in clinical applications Cord-id: b1e0bbrp Document date: 2017_10_12
ID: b1e0bbrp
Snippet: Since 1985, interferon (IFN)-ω, a type I IFN, has been identified in many animals, but not canines and mice. It has been demonstrated to have antiviral, anti-proliferation, and antitumor activities that are similar to those of IFN-α. To date, IFN-ω has been explored as a treatment option for some diseases or viral infections in humans and other animals. Studies have revealed that human IFN-ω displays antitumor activities in some models of human cancer cells and that it can be used to diagnos
Document: Since 1985, interferon (IFN)-ω, a type I IFN, has been identified in many animals, but not canines and mice. It has been demonstrated to have antiviral, anti-proliferation, and antitumor activities that are similar to those of IFN-α. To date, IFN-ω has been explored as a treatment option for some diseases or viral infections in humans and other animals. Studies have revealed that human IFN-ω displays antitumor activities in some models of human cancer cells and that it can be used to diagnose some diseases. While recombinant feline IFN-ω has been licensed in several countries for treating canine parvovirus, feline leukemia virus, and feline immunodeficiency virus infections, it also exhibits a certain efficacy when used to treat other viral infections or diseases. This review examines the known biological activity of IFN-ω and its clinical applications. We expect that the information provided in this review will stimulate further studies of IFN-ω as a therapeutic agent.
Search related documents:
Co phrase search for related documents- acute phase and additive effect: 1
- acute phase and liver disease: 1, 2, 3, 4, 5, 6
- acute phase and low activity: 1, 2
- acute phase and lung protein: 1, 2, 3, 4, 5, 6, 7
- acute phase and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- acute phase protein and low activity: 1
- acute phase protein and lung protein: 1
- acute phase protein and lung tissue: 1
- additional research and liver disease: 1, 2
- additional research and location characteristics: 1
- additional research and low activity: 1
- liver disease and low activity: 1, 2, 3, 4
- liver disease and lung protein: 1, 2
- liver tumor and location characteristics: 1
Co phrase search for related documents, hyperlinks ordered by date